Unicef selects ultra-low temperature (ult) freezers from biolife solutions to extend thermal stability of covid-19 vaccines

Bothell, wash., dec. 16, 2021 /prnewswire/ -- biolife solutions, inc. (nasdaq: blfs), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("cgt") and broader biopharma markets, today announced a partnership with unicef to extend thermal stability of temperature-sensitive covid-19 vaccines in developing communities in africa, the middle east and south america where limited power infrastructure and extreme environmental conditions make it difficult for most ult freezers to remain operational.
BLFS Ratings Summary
BLFS Quant Ranking